How It Works: DPP-4 inhibitors slow the enzymatic breakdown of GLP-1, effectively extending its half-life in circulation
it results in altered absorption kinetics and a higher risk of bruising and local pain
Dogulu CF, Tsilou E, Rubin B, Fitzgibbon EJ, Kaiser-Kupper MI, Rennert OM, Gahl WA (2004) Idiopathic intracranial hypertension in cystinosis
A su vez, el ensayo SELECT, con ms de 17.000 participantes, demostr que reduce en un 20% el riesgo de muerte cardiovascular, infarto y accidente cerebrovascular en personas con obesidad y enfermedad cardaca previa
Doniach I
A meta-analysis also showed that GLP-1 RAs could reduce depression severity scores, with a greater impact on diabetic participants [Reference Pozzi, Mazhar, Peeters, Vantaggiato, Nobile, Clementi and Nobile50]